Skip to main content
LL

Liberation Labs

Liberation Labs utilizes precision fermentation technology to produce alternative proteins and bioproducts at commercial scale, addressing the capacity bottlenecks in biomanufacturing. Their facility in Indiana aims to meet the growing demand for sustainable and environmentally friendly food and materials, enabling manufacturers to efficiently scale their production.

East New York, United StatesFounded 2021183K+ followers
Updated 20 months ago

Funding

$2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

A
Funding rounds are not available yet.

Founders

Product

Problem

Biomanufacturing companies face significant bottlenecks in scaling production of alternative proteins and other bioproducts due to limited access to suitable fermentation facilities. Existing facilities are often designed for pharmaceutical applications and lack the efficiency and cost-effectiveness required for food-grade biomanufacturing.

Solution

Liberation Bioindustries addresses this capacity gap by providing purpose-built, commercial-scale precision fermentation facilities for manufacturing a variety of bioproducts. Their facilities are designed to meet the specific needs of the bioeconomy, offering reliable, bespoke, and cost-effective solutions for novel bioproduct manufacturers. By investing in modern, domestic infrastructure, Liberation Bioindustries reduces production bottlenecks and enables companies to efficiently scale up fermentation-based products, bridging the gap between R&D and full commercial production. The company's approach strengthens global supply chains and ensures that biotech innovators have the manufacturing capacity needed to bring groundbreaking products to market.

Target Audience

Liberation Bioindustries serves biotechnology companies, including alternative protein startups, established ingredient companies, and CPG brands, that require commercial-scale precision fermentation manufacturing.

Features

  • Industrial-scale precision fermentation capacity with a 600,000-liter fermentation plant
  • Dedicated downstream processing (DSP) capabilities, including microfiltration, ultrafiltration, and spray-drying
  • Facilities designed specifically for food-grade biomanufacturing, ensuring efficiency and cost-effectiveness
  • Strategic site selection based on access to sugar feedstocks, energy, and skilled labor
  • Capability to produce a range of bioproducts, including alternative proteins, specialty chemicals, and pharmaceutical ingredients
  • Focus on strengthening domestic supply chains and reducing reliance on overseas production
This profile is AI-generated and may contain inaccuracies.